CING Cingulate Inc Com
0%
Previous Close
Open
52 Week Low
52 Week High
Market Cap
$0
Shares
20,448,044
Float
13,136,515
Enterprise Value
$0
Volume
0
Av. Daily Volume
0
Drug Pipeline
| Drug | Stage | Notes |
|---|---|---|
|
CTx-1301 (dexmethlyphenidate HCI)
ADHD
|
Phase 2
Phase 2
|
Phase 3 initiation 4Q 2021.
|
|
CTx-1302 (dextroamphetamine suffate)
ADHD
|
Phase 1
Phase 1
|
Phase 1 and 2 initiation due 2022
|